At a glance
- Originator Fisons
- Class Neuroprotectants; Nootropics; Small molecules
- Mechanism of Action Muscarinic M1 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cognition disorders
Most Recent Events
- 01 Aug 1996 Discontinued-Preclinical for Cognition disorders in United Kingdom (Unknown route)
- 15 May 1995 Discontinued-Preclinical for Cognition disorders in USA (Unknown route)